Source: Radiation Oncology. Unidade: FM
Subjects: PERDA AUDITIVA, RADIOTERAPIA, QUALIDADE DE VIDA, MEDULOBLASTOMA, NEOPLASIAS CEREBRAIS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Wilson Albieri et al. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): A retrospective review. Radiation Oncology, n. 1, p. 6 , 2014Tradução . . Disponível em: https://doi.org/10.1186/1748-717x-9-158. Acesso em: 05 out. 2024.APA
Vieira, W. A., Weltman, E., Chen, M. J., Silva, N. S. da, Cappellano, A. M., Pereira, L. D., et al. (2014). Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): A retrospective review. Radiation Oncology, ( 1), 6 . doi:10.1186/1748-717x-9-158NLM
Vieira WA, Weltman E, Chen MJ, Silva NS da, Cappellano AM, Pereira LD, Gonçalves MIR, Ferrigno R, Hanriot RM, Nadalin W, Odone Filho V, Petrilli AS. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): A retrospective review [Internet]. Radiation Oncology. 2014 ;( 1): 6 .[citado 2024 out. 05 ] Available from: https://doi.org/10.1186/1748-717x-9-158Vancouver
Vieira WA, Weltman E, Chen MJ, Silva NS da, Cappellano AM, Pereira LD, Gonçalves MIR, Ferrigno R, Hanriot RM, Nadalin W, Odone Filho V, Petrilli AS. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): A retrospective review [Internet]. Radiation Oncology. 2014 ;( 1): 6 .[citado 2024 out. 05 ] Available from: https://doi.org/10.1186/1748-717x-9-158
